you are here: Home News Boaml

Boaml

Earnings recovery continues to be elusive, see positive policy surprises: BoAML
Tata Motors soars 4% on domestic & JLR sales, BoAML ups target
Expect Sensex companies to deliver robust profit growth: BoAML
Idea slips on downgrade, BoAML sees further weakness in revenue
Demonetisation, GST keep active investors on sidelines: Mishra
Analysts positive on NBFCs, retail private banks after RBI move
Add utilities, pharma, staples, OMCs stocks to portfolio: BoAML
Banks sink 7% amid US polls woes; but analysts see strong growth
BoAML retains buy on Aurobindo, sees 23% EPS CAGR over FY16-18
Pending order pipeline, turnaround in US key for Aurobindo:BoAML
Brexit impact limited on pharma, US biz to offset risk: Analysts
What now for UK? Brokerages give you a lowdown
Hindalco up 3%; BoAML retains buy on B/S, Novelis product mix
BoML upgrades Bharti to buy led by steady growth; stock up 3%
BoAML ups target & EPS of Shriram Transport on growth, margins
ITC up 8% post Q4, brokers raise target on cigarette rebound
Motherson up 2%, BoAML reiterates buy on strong growth prospect
PI Ind jumps 4%; BoAML expects co to outperform EPS estimates
Aurobindo up 1%; gets third USFDA nod in 2 days, BoAML positive
Godrej Consumer up 10%, BoAML sees margin-led growth in Q2
YES Bank up over 1%; BoAML retains buy, sees 70% upside
Glenmark Pharma falls 6%; BoAML downgrades to underperform
Mylan's Asthma drug launch in UK negative for Cipla: BoAML
Bharat Forge slips 3% on BoAML downgrade, target cut too
Sun Pharma, Lupin, Cipla, Cadila plunge on BoAML downgrade

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Boaml

Earnings recovery continues to be elusive, see positive policy surprises: BoAML

Tata Motors soars 4% on domestic & JLR sales, BoAML ups target

Expect Sensex companies to deliver robust profit growth: BoAML

Idea slips on downgrade, BoAML sees further weakness in revenue

Demonetisation, GST keep active investors on sidelines: Mishra

Analysts positive on NBFCs, retail private banks after RBI move

Add utilities, pharma, staples, OMCs stocks to portfolio: BoAML

Banks sink 7% amid US polls woes; but analysts see strong growth

BoAML retains buy on Aurobindo, sees 23% EPS CAGR over FY16-18

Pending order pipeline, turnaround in US key for Aurobindo:BoAML

Brexit impact limited on pharma, US biz to offset risk: Analysts

What now for UK? Brokerages give you a lowdown

Hindalco up 3%; BoAML retains buy on B/S, Novelis product mix

BoML upgrades Bharti to buy led by steady growth; stock up 3%

BoAML ups target & EPS of Shriram Transport on growth, margins

ITC up 8% post Q4, brokers raise target on cigarette rebound

Motherson up 2%, BoAML reiterates buy on strong growth prospect

PI Ind jumps 4%; BoAML expects co to outperform EPS estimates

Aurobindo up 1%; gets third USFDA nod in 2 days, BoAML positive

Godrej Consumer up 10%, BoAML sees margin-led growth in Q2

YES Bank up over 1%; BoAML retains buy, sees 70% upside

Glenmark Pharma falls 6%; BoAML downgrades to underperform

Mylan's Asthma drug launch in UK negative for Cipla: BoAML

Bharat Forge slips 3% on BoAML downgrade, target cut too

Sun Pharma, Lupin, Cipla, Cadila plunge on BoAML downgrade